Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the OPTtimum Duration of Acoustic Pulse ThromboLYSis ProcEdure in the Treatment of Acute Submassive Pulmonary Embolism

NCT02396758 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02396758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02396758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the OPTtimum Duration of Acoustic Pulse ThromboLYSis ProcEdure in the Treatment of Acute Submassive Pulmonary Embolism
Lead sponsor
Boston Scientific Corporation
Phase
Phase 4
Overall status
Completed
Start date
June 12, 2015
Completion date
January 30, 2020
Enrollment
131 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism and thrombosis